GENVOR INC

Genvor, Inc. (OTCQB: GNVR) is a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health. Powered by its proprietary BioCypher™ platform and patented peptides, Genvor is developing and intends to commercialize biological actives for crop protection and plant health alongside consumer-focused peptide solutions for recovery, performance, anti-aging, and daily wellness. Through its technology platforms and future partnerships, Genvor intends to advance a new era of natural, science-based innovation. For more information, visit www.genvor.com.

Current securities

1. DEF 14C filingJul 31, 2026
2. PRE 14C filingJul 20, 2026
3. Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesJun 22, 2026
4. 3 filingMay 26, 2026
5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsMay 21, 2026